Company intelligence / Profile preview

Panosome

Heidelberg, Baden-Württemberg, Germanypanosome.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Panosome has developed a proprietary platform technology, VAST, that enables the generation of high-titer antibodies against challenging targets such as small molecules, peptides, proteins, sugars, and lipids. The company is leveraging this platform to develop monoclonal antibodies for research and therapeutic use—most notably targeting tumor markers like MUC1 in pancreatic cancer. Early results indicate superior antibody titers compared to traditional methods. The company recently secured nearly €2 million in government funding to advance its lead program against pancreatic cancer into further development stages[4].

Therapeutic areas: ImmunologyOncology
Modalities: Monoclonal antibodyAntibodyNanoparticle (for delivery applications)
Industry: Biotech

Drug pipeline

2 assets

MUC-4

Preclinical

1 more asset in the full pipeline.

Request access →

Partnerships

Several leading pharmaceutical companies as partners for tailored product development; specific names not disclosedDKFZ is a key academic partner/spin-off originator.

Beyond the preview

Go deeper on Panosome.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Panosome.

Explore the full profile